Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IoniCell is a dietary supplement formulated with Ioniplex, a proprietary fulvic ionic mineral complex derived from ancient plant matter. Developed by Mineral BioSciences, it is designed to support cellular health, metabolic function, and the structural integrity of hair, skin, and nails. The primary active component, fulvic acid, acts as a potent natural chelator and ionophore, significantly enhancing the bioavailability and cellular uptake of essential minerals and nutrients. Beyond its role in nutrient transport, IoniCell exhibits significant antioxidant properties by neutralizing reactive oxygen species and has been shown to inhibit the formation of advanced glycation end products (AGEs). This dual action helps protect cells from oxidative damage and mitigates the cellular aging processes associated with protein glycation, particularly in the context of glucose management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IoniCell.